サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：呼気分析器と薬物検査装置の世界市場-2023-2030
市場調査レポート
商品コード
1176572

呼気分析器と薬物検査装置の世界市場-2023-2030

Global Breathalyzer and Drug Testing Equipment Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
呼気分析器と薬物検査装置の世界市場-2023-2030
出版日: 2022年12月26日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

呼気分析器と薬物検査装置の市場規模は、予測期間（2023-2030年）に16.8%のCAGRで成長するとされています。

アルコール検査装置は、警察、産業、個人の用途において、迅速、確実、かつ衛生的に事前検査を実施します。また、呼気分析器は、過去の検査結果に素早くアクセスするためのデータ保存機能を備えています。飲酒検査は、診断装置を用いて人の血中アルコール濃度（BAC）を推定します。デバイスに息を吹きかけることによって、人は、彼らが運転する法定制限を超えているかどうかを判断することができます。人の体内のアルコール、またはエタノールの量を測定するには、血液、唾液、尿、または呼気のサンプルが必要です。

市場力学

呼気分析器と薬物検査装置の世界市場は、技術的進歩によって牽引されています。呼気分析器と薬物検査装置の採用が拡大していること、飲酒運転事件や薬物中毒の増加、薬物やアルコールの影響下での運転事故を減らすための政府の厳しい規制や法律が市場を後押ししています。

薬物やアルコールの影響下での運転事故の増加が市場成長を後押し

薬物やアルコールの影響下での運転事故を減らすための厳しい政府の規制や法律が、予測期間中の市場を牽引します。世界保健機関レポート2022によると、道路交通傷害は主要な公衆衛生問題であり、世界中で死傷の最たる原因となっています。毎年約130万人が死亡し、数百万人が交通事故による負傷や障害を負っており、そのほとんどが低・中所得国でのことです。交通事故死傷は、個人、家族、地域社会に莫大な社会的コストをもたらすだけでなく、医療サービスや経済にも大きな負担を与えています。

アルコールは多くの社会で文化的・社会的役割を担っています。しかし、日常生活の多くの場面で経験するアルコールの有害性は否定できないです。多くの文献によると、飲酒後の運転は事故のリスクとその重症度を著しく高め、死者や重傷者を出すことが明らかにされています。

WHOは最新の報告書で、世界の交通事故死の5％～35％がアルコール関連であると推定しています。ほとんどの高所得国では、死亡事故を起こした促進要因の約20％が血中アルコール濃度が法定制限値を超えています。低・中所得国での調査では、死亡事故を起こした促進要因の33%と69%、死亡事故を起こさなかった促進要因の8%と29%が、事故前にアルコールを摂取していたことが明らかになっています。薬物やアルコールの影響下での事故が増加し、政府の規制が強化されていることが、世界の市場を牽引しています。

呼気分析器の中には、不正確で間違った結果を出すものがあり、市場の成長を阻害します

しかし、呼気分析器の中には、不適切な校正、不適切な化学溶液、不適切な改造、誤ったプログラミング、不適切な方法、電子的干渉、特定の健康状態、化学物質への暴露などにより、不正確で間違った結果を出すものがあります。これらの要因が市場成長を阻害しています。

COVID-19の影響分析

COVID-19の登場は、世界の呼気分析器と薬物検査装置市場にプラスの影響を与えました。2021年のDisaster Medicine and Public Health Preparednessに掲載された記事によると、コロナウイルス病2019の大流行により、地域社会の発生に対処し、病気の広がりを評価するために、正確で迅速、かつ簡単に投与できる診断ツールへの需要があるとのことです。呼気分析技術に含まれる人工知能は、呼気中の揮発性有機化合物を分析することで、がんや肺疾患などのさまざまな病気を診断できる可能性が示されています。そのため、迅速で使いやすく、非侵襲的であることから、大規模な公衆衛生活動においてCOVID-19の診断に使用するのに適していると考えています。

2022年4月、米国食品医薬品局は、SARS-CoV-2感染に関連する呼気サンプル中の化学物質を検出する最初のCOVID-19診断検査に対して緊急使用認可を発行しました。この検査は、医院、病院、移動検査場など、患者の検体を採取して検査する環境において、機内持ち込み手荷物程度の大きさの機器を利用して実施することができます。

COVID-19は、ガスクロマトグラフ質量分析計（GC-MS）を用いて化学物質の混合物を分離・同定し、呼気中のSARS-CoV-2感染に関連する5種類の揮発性有機化合物（VOC）を迅速に検出する装置で、InspectIR COVID-19 BreathalyzerがSARS-CoV-2のVOCマーカーを検出すると仮想的（未確認）陽性検査結果が得られ、分子検査による確認が必要です。

目次

第1章 市場調査手法とスコープ

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 事故件数の増加
      • 啓蒙活動の増加
    • 抑制要因
      • 不正確な診断
    • ビジネスチャンス
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 製品タイプ別

  • 酸化物半導体型呼気分析器
  • 燃料電池式呼気分析器
  • 分光光度計型呼気分析器

第8章 アプリケーション別

  • アルコール検知
  • 薬物検出
  • 気管支喘息検知
  • 結核検査
  • 法医学検査
  • その他

第9章 エンドユーザー別

  • 連邦政府機関
  • 病院
  • リハビリテーションセンター
  • 民間企業
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • タイプ別ベンチマーク

第12章 企業プロファイル

  • C4 Development
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Cannabix Technologies Inc.
  • Intoxalock
  • Hound Labs
  • BACtrack
  • Lion Laboratories Limited
  • Intoximeters, Inc.
  • Lifeloc Technologies, Inc.
  • Lifesafer
  • Ekips Technologies

第13章 呼気分析器と薬物検査装置の世界市場-DataM

目次
Product Code: DMCD1129

Market Overview

Breathalyzer And Drug Testing Equipment Market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 16.8% during the forecast period (2023-2030).

Alcohol screening devices perform pretests in police, industrial and personal applications fast, reliable and hygienically. The breathalyzers also provide data storage for quick access to past test results. A breathalyzer test uses a diagnostic device to estimate a person's blood alcohol content (BAC). By blowing into the device, a person can determine whether they are over the legal limit to drive. Measuring the amount of alcohol, or ethanol, in a person's system requires a blood, saliva, urine, or breath sample.

Market Dynamics

Technological advancements drive the global breathalyzer and drug testing equipment market. The growing adoption of breathalyzers and drug testing equipment, the increasing number of drunk and drive cases and drug addiction and stringent government regulations and laws to reduce driving incidences under the influence of drugs and alcohol boosts the market.

Rising driving incidences under the influence of drugs and alcohol drives market growth

The stringent government regulations and laws to reduce driving incidences under the influence of drugs and alcohol drive the market in the forecast period. As per the World Health Organization Report 2022, road traffic injuries are a major public health problem and a foremost cause of death and injury worldwide. Every year around 1.3 million people die, and millions more are injured or disabled due to road crashes, mostly in low- and middle-income countries. As well as creating enormous social costs for individuals, families and communities, road traffic injuries heavily burden health services and economies.

Alcohol plays a cultural and social role in many societies. However, the harmful effects of alcohol experienced in many aspects of daily life are undeniable. An extensive body of literature identifies that driving after drinking alcohol significantly raises the risk of a crash and the severity of that crash, resulting in deaths and serious injuries.

In its latest reports, the WHO estimates that between 5% and 35% of global road deaths are alcohol-related. In most high-income countries, about 20% of fatally injured drivers have blood alcohol concentration levels above the legal limit. Studies in low- and middle-income countries have shown that 33% and 69% of fatally injured drivers and 8% and 29% of non-fatally injured drivers had consumed alcohol before their crashes. The rising incidences under the influence of drugs and alcohol and rising government regulations drive the market worldwide.

The inaccurate and wrong results provided by some breathalyzers will hamper the growth of the market

However, inaccurate and wrong results are provided by some breathalyzers due to improper calibration, incorrect chemical solutions, inappropriate modifications, faulty programming, improper methodology, electronic interference, certain health conditions, and exposure to chemicals. These factors are hampering the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 positively impacted the global breathalyzer and drug testing equipment market. According to the article published in Disaster Medicine and Public Health Preparedness in 2021, due to the coronavirus disease 2019 pandemic, there is a demand for accurate, rapid, and easy-to-administer diagnostic tools to support communities address local outbreaks and assess the spread of disease. Artificial intelligence within breath analysis techniques has been shown to potentially diagnose various diseases, such as cancer and lung disease, by analyzing volatile organic compounds in exhaled breath. This, combined with their rapid, easy-to-use, and noninvasive nature, makes them a suitable candidate for use in diagnosing COVID-19 in large-scale public health operations.

In April 2022, the U.S. Food and Drug Administration issued an emergency use authorization for the first COVID-19 diagnostic test that detects chemical compounds in breath samples related to a SARS-CoV-2 infection. The test can be conducted in environments where the patient specimen is collected and examined, such as doctor's offices, hospitals and mobile testing sites, utilizing an instrument about the carry-on luggage size.

The InspectIR COVID-19 Breathalyzer employs gas chromatography gas mass-spectrometry (GC-MS) to isolate and identify chemical mixtures and quickly detect five Volatile Organic Compounds (VOC) associated with SARS-CoV-2 infection in an exhaled breath when the InspectIR COVID-19 Breathalyzer detects VOC markers of SARS-CoV-2, a hypothetical (unconfirmed) positive test result is produced and should be confirmed with a molecular test.

Segment Analysis

The alcohol detection segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The alcohol detection segment accounts for the largest market share. Imagine the loss of lives caused due to people driving under the influence of alcohol. Through our alcohol detection device, police officers can instantly figure out people driving under the influence of alcohol and stop them, reducing drunk driving scenarios.

Manufacturers are providing the products in the market. For instance, Lifeloc Technologies, Inc. is a trusted U.S. manufacturer of precise, reliable And easy-to-use portable breath alcohol testing instruments (breathalyzers). Lifeloc's L Series of portable breath alcohol testers or "breathalyzers" are state-of-the-art and the most powerful, simple to use and advanced product on the market.

Also, in October 2022, Cannabix Technologies Inc., developer of breath testing devices for law enforcement and the workplace, reported that the Company had created a cutting-edge Contactless Alcohol Breathalyzer for workplaces and vehicles. Cannabix engineers have developed a suite of Contactless Alcohol Breathalyzer (CAB) offerings, including wall-mounted and in-vehicle (behind the steering column) versions.

Geographical Analysis

North America region holds the largest market share of the global Breathalyzer and Drug Testing Equipment market

North America dominates the breathalyzer and drug testing equipment market and is anticipated to show a parallel trend over the forecast period. An increasing number of accidents and awareness programs in the North American region drive the market.

According to the WHO report 2022, consuming alcohol can be an enjoyable activity for some people. However, many people may not realize the impact on body and can impair the ability to perform routine tasks. Drinking and driving is a dangerous combination. Evidence notes that in the U.S., it is responsible for roughly 28 deaths a day, costing the U.S. approximately $44 billion annually.

In the U.S., half a million people are injured and 17,000 killed every year in drunk driving-related traffic crashes. Almost 40% of all youth road fatalities are directly related to alcohol consumption.

Using breathalyzers can help reduce the number of motor vehicle accidents involving an alcohol-impaired driver. This device estimates the concentration of alcohol in the breath to decide whether a person has drunk too much alcohol to drive safely. All these factors are driving the market in the North American region.

Competitive Landscape

The breathalyzer and drug testing equipment market are a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are C4 Development, Cannabix Technologies Inc., Intoxalock, Hound Labs, BACtrack, Lion Laboratories Limited, Intoximeters, Inc., Lifeloc Technologies, Inc., Lifesafer, and Ekips Technologies, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the breathalyzer and drug testing equipment market globally.

For instance,

In October 2022, Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace, reports it will be partaking in a mid-October study date to test a supplemental version of its FAIMS technology for the detection of Delta 9-tetrahydrocannabinol and related analytes in human breath in a complete multi-analysis study of subjects under the effect of marijuana in the southern United States.

C4 Development

Overview:

C4 Development provides the most advanced tailor-made alcohol tester and ITS products to different countries. Alcovisor, a series of alcohol breath analyzers created and manufactured by the company. Alcovisor provides drivers with a testing machine to measure their alcohol degree before driving.

Product Portfolio:

JupiterX: This is android 5.1, built-in printer, GPS, 4G/WIFI Photo Capture, provide evidential records by auto-capturing while subject blowing, 100,000 test data stored in memory, 4.3" color touch screen. The mouthpiece can be automatically ejected, and a USB PC connection.

The global breathalyzer and drug testing equipment market report would provide access to approximately 55+ market data tables, 55+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing number of accidents
      • 4.1.1.2. Increase in the number of awareness programs
    • 4.1.2. Restraints:
      • 4.1.2.1. Inaccurate diagnosis
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Semiconductor Oxide Breathalyzers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Fuel Cell Breathalyzers
  • 7.4. Spectrophotometer Breathalyzers

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Alcohol Detection*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Drug Detection
  • 8.4. Asthma Detection
  • 8.5. Tuberculosis Detection
  • 8.6. Forensic Test
  • 8.7. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Federal Departments*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Hospitals
  • 9.4. Rehabilitation Centers
  • 9.5. Private Sectors
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Type Benchmarking

12. Company Profiles

  • 12.1. C4 Development*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Cannabix Technologies Inc.
  • 12.3. Intoxalock
  • 12.4. Hound Labs
  • 12.5. BACtrack
  • 12.6. Lion Laboratories Limited
  • 12.7. Intoximeters, Inc.
  • 12.8. Lifeloc Technologies, Inc.
  • 12.9. Lifesafer
  • 12.10. Ekips Technologies

LIST NOT EXHAUSTIVE

13. Global Breathalyzer and Drug Testing Equipment Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us